drugset / Trial / NCT04979572
A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)
RandomizedParallel-groupDouble-blindBasic science
Summary
A Phase 1, Single-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending and Multiple Dose of TS-172 in Healthy Adult Subjects
Timeline
- Start
- 2021-08-16
- Primary completion
- 2022-01-26
- Completion
- 2022-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-172 | Unknown | 10 mg | — |
| Subject | TS-172 | Unknown | 30 mg | — |
| Subject | TS-172 | Unknown | 90 mg | — |
| Subject | TS-172 | Unknown | 270 mg | — |
Indications
No indication recorded.